Editorial corrections and citation queries.

The editorial inbox is for corrections to factual claims on the site (a citation that does not support the quoted finding, a misstated dose value, a misattributed paper, a regulatory action mischaracterized), questions about the methodology used to assemble the dossier, and requests to clarify the inclusion or exclusion of a particular source.

If you believe a quantitative claim on this site does not match its cited source, please include the page name, the section heading, the specific claim, and a pointer to the source — DOI, PMID, NCT identifier, or stable URL. We treat citation errors as the most important class of correction and prioritize them in the inbox.

We do not provide medical advice. We are an editorial project that summarizes research; we are not clinicians, and the published CJC-1295 record does not support clinical advice in any case. Requests for dosing recommendations, individual treatment plans, side-effect assessments, drug-interaction queries, prescriptions, or any other clinical service will be declined.

We do not provide vendor or compounding-pharmacy referrals. The site does not maintain commercial relationships with any source of CJC-1295 or any related peptide and is not in a position to recommend one. Inquiries about where to purchase any compound will be declined.

We do not provide affiliate or partnership inquiries on this address. The editorial project is non-commercial in its current Phase 1 form.

A simple contact form is provided below. Please use a working return address. Editorial correction queues are read weekly, not daily.